Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01944722 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
A NA study of Uterine Cervical Neoplasms, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- NA
- Development phase
- 33,858
- Enrollment target
- 20
- Study locations
NCT01944722 is a NA study of Uterine Cervical Neoplasms that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 33,858 participants, above the 1,321-participant average among 8 other Uterine Cervical Neoplasms trials with a reported enrollment target (2463% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT01944722, a NA study of Uterine Cervical Neoplasms, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 33,858 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to compare the results of the Becton Dickinson (BD) Onclarity™ Human Papilloma Virus (HPV) Assay on the BD Viper™ LT instrument from liquid-based cytology (LBC) media diluted in BD HPV LBC diluent to adjudicated histology results from biopsy and a molecular composite comparator.
Conditions Studied
Interventions
- PROCEDURE Colposcopy
- DEVICE BD Onclarity™ HPV assay on BD Viper™ LT
Study Locations (20)
Florida
- Health Awareness Inc - Jupiter
- Altus - Lake Worth
- Segal Institute for Clinical Research - North Miami
- Miami Research Associates - South Miami
- Comprehensive Clinical Trials, LLC - West Palm Beach
Arizona
- Women's Health Research of Arizona - Phoenix
- Quality of Life Medical & Research Center - Tucson
- Visions Clinical Research - Tucson
Alabama
- University of Alabama Birmingham - Birmingham
- Mobile OB/GYN - Mobile
California
- Women's Health Care Research Corp - San Diego
- West Coast Medical Research - San Diego
Georgia
- Medical Network for Education and Research - Decatur
- Fellows Research Associates - Savannah - Savannah
Colorado
- Blueskies Center for Women - Colorado Springs
Illinois
- Women's Health Practice - Champaign
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33,858 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01944722
The ClinicalTrials.gov registry entry for NCT01944722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33,858 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,321-participant average among 8 other Uterine Cervical Neoplasms trials with a reported enrollment target (2463% higher). The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Cervical Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Colposcopy is the first listed.
NCT01944722 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT01944722 about?
NCT01944722 is a clinical study titled "Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens". The purpose of the study is to compare the results of the Becton Dickinson (BD) Onclarity™ Human Papilloma Virus (HPV) Assay on the BD Viper™ LT instrument from liquid-based cytology (LBC) media diluted in BD HPV LBC diluent to adjudicated histology results from biopsy and a molecular composite comp...
What is the current status of trial NCT01944722?
This trial is currently completed. It is a NA study. The enrollment target is 33,858 participants. The study started on 2013-08. Estimated completion is 2016-03.
What conditions does trial NCT01944722 study?
This clinical trial studies the following conditions: Uterine Cervical Neoplasms.
What interventions are being tested in trial NCT01944722?
The interventions under investigation include: Colposcopy (PROCEDURE), BD Onclarity™ HPV assay on BD Viper™ LT (DEVICE).
Who is sponsoring clinical trial NCT01944722?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01944722 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Cervical Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
RECRUITING · NA
-
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
COMPLETED · NA
-
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
RECRUITING · Phase 1
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
ACTIVE NOT RECRUITING
-
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.